CD44 and lung carcinoma: Using IPA’s Biomarker Filter (Homo sapiens; cancer; lung cancer cell lines), three genes in our panel mapped to established biomarkers (not specifically for MMP12 inhibition): ADAM9 (efficacy/prognosis), CD44 (diagnosis/progression/prognosis), and MMP12 (efficacy).